MOR209/ES414, a Novel Bispecific Antibody Targeting PSMA for the Treatment of Metastatic Castration-Resistant Prostate Cancer.
Mol Cancer Ther
; 15(9): 2155-65, 2016 09.
Article
in En
| MEDLINE
| ID: mdl-27406985
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antibodies, Bispecific
/
Glutamate Carboxypeptidase II
/
Prostatic Neoplasms, Castration-Resistant
/
Antineoplastic Agents
Type of study:
Prognostic_studies
Limits:
Animals
/
Humans
/
Male
Language:
En
Journal:
Mol Cancer Ther
Journal subject:
ANTINEOPLASICOS
Year:
2016
Document type:
Article
Country of publication: